Hims & Hers Halts Compounded Semaglutide Pill Offering After FDA's Crackdown Warning

Hims & Hers to cease offering compounded semaglutide pill due to FDA warning and legal threats.

Gain access to strategic insights and signals that highlight where the smart money is moving.

Hims & Hers Halts Compounded Semaglutide Pill Offering After FDA's Crackdown Warning Hims & Hers to cease offering compounded semaglutide pill due to FDA warning and legal threats. More Info ➔ Congressman Who Bought Small-Cap Stocks In 2025 Is Back With New 2026 Pick: Here's What He's Buying A member of Congress is buying stock in two small cap companies in 2026. Here's the stocks and why investors should be watching. More Info ➔ New Law: Trump Just Triggered a $382 Trillion Money Migration - Ad A new "Commodity Crunch" may be starting now. After oil, uranium, and rare earth booms, a legendary tech investor says a blockchain-based Money Grid could ignite demand for a scarce "Digital Oil." Same historic pattern - potentially massive gains ahead. Get positioned in Digital Oil before this window closes Cathie Wood Sees Opportunity in Robinhood's Crypto Weakness? Ark Buys HOOD Stock Worth 34 Million, Dumps Airbnb Ahead Of Earnings Ark Invest bought $34M in Robinhood shares on Wednesday, Jan. 11, 2026, despite an 8% stock drop following a 38% plunge in crypto revenue. More Info ➔ Imperial Petroleum Shares Climb After $10 Million Buyback Imperial Petroleum Inc (NASDAQ: IMPP) shares are trading higher Monday afternoon after the company announced a new share repurchase program. More Info ➔ SpaceX IPO Confirmed: Claim Your Stake Today - Ad Elon Musk is about to take SpaceX public in what's set to be the biggest IPO ever. But there's no need to wait for the company to go public. You can claim your stake today. The New York Times predicted it "will unleash gushers of cash for Silicon Valley and Wall Street." More Info ➔ After deadly explosion at US Steel mill outside Pittsburgh, maintaining safety now falls to Nippon CLAIRTON, Pa. (AP) — For Don Furko, Aug. 11, 2025, was a normal shift. Until it became the shift he would never forget. More Info ➔ What's Going On With Navitas Semiconductor Stock? Shares of Navitas Semiconductor Corporation (NASDAQ: NVTS) are falling amid a broader technology stock sell-off, despite the company launching a fifth-generation platform that will lead to better data center efficiencies. More Info ➔ Is This Stock AI's Next Victim? - Ad A single AI update erased $300 billion in one day. Another wiped out $1 trillion the week before. CNBC legend and trading veteran Jon Najarian says dozens more stocks are in the crosshairs right now, and most investors have no idea. Go here for the full story. Howard Lutnick 'Should Just Resign' Over Epstein Ties, Thomas Massie Says: Here's Which Companies Would Benefit From That Howard Lutnick may leave Trump admin in 2026, as markets predict. His resignation would affect companies like TSM, Samsung, and Caterpillar. More Info ➔ Why Is Ultragenyx Stock Sinking Friday? Ultragenyx reports mixed Q4 earnings and initiates strategic restructuring plan to align resources with potential product launches. More Info ➔ The No.1 Stock to Buy Before the SpaceX IPO - Ad Bloomberg is calling Elon Musk's upcoming SpaceX IPO "the biggest listing of ALL TIME." But here's the thing - most investors will be locked out until AFTER it goes public. Not you. I've found a 'backdoor' that lets everyday Americans grab a pre-IPO stake in SpaceX right now. Go here for the free "SpaceX" ticker Warren Accuses Trump, Musk Of Undermining CFPB, Trump Tariffs Could Cost Households $1,300 And More: This Week In Politics Warren accuses Trump and Musk of undermining CFPB, tariffs could cost $1300/yr, Musk supports GOP, Trump censors student loan report. More Info ➔ OpenAI Snags OpenClaw Creator Peter Steinberger To Lead Next-Generation AI Agents OpenAI has hired Peter Steinberger, creator of OpenClaw, to lead the development of next-generation personal AI agents. More Info ➔ Johnson & Johnson Reports 90% AFib Freedom In Early Heart Device Study Johnson & Johnson shared early AFib study results showing 90% success and no safety issues, but the stock lagged as healthcare stocks outperformed broader markets. More Info ➔ QXO, Apollo Global, Thermo Fisher Scientific And More On CNBC's 'Final Trades' Shares of QXO rose 4.4% to close at $27.07 on Friday; Thermo Fisher slipped 1% to $504.82; and Apollo Global edged down 0.2% to $125.07 More Info ➔ In the shadow of the Clairton Coke Works, the community's next generation learns CLAIRTON, Pa. (AP) — At 2 p.m. on a chilly January afternoon, the elementary floor of the Clairton City School District’s building was buzzing. More Info ➔ Clinical Research Provider Icon Stock Crashes On Accounting Probe Icon shares drop after the company flags a revenue review, possible weak controls, and withdraws 2025 guidance, delaying results as analysts turn cautious. More Info ➔

Information, charts, or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising and partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted into our newsletter. If you wish to no longer receive these offers, click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons, we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices, or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct, or truthful. If you use, act upon, or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates, and agents without fault. 2967 Dundas St. W. #990, Toronto, ON M6P 1Z2 | Phone Number: 917.672.7040 © 2026 Musth | SmartMoneyTrading | All rights reserved. UNSUBSCRIBE

Share on Facebook

Share on Twitter

Share on Google+

Share on LinkedIn

Subscribe to receive free email updates: